Neuro-Oncology Advances
Scope & Guideline
Connecting minds to revolutionize neuro-oncology practices.
Introduction
Aims and Scopes
- Molecular and Genetic Characterization of Brain Tumors:
Research focused on the molecular profiling of brain tumors, including gliomas, meningiomas, and other central nervous system (CNS) tumors to identify genetic alterations and their implications for prognosis and treatment. - Innovative Therapeutic Approaches:
Exploration of novel therapeutic strategies, including targeted therapies, immunotherapies, and combination treatments, aimed at improving outcomes for patients with brain tumors. - Clinical Trials and Treatment Optimization:
Publishing results from clinical trials that assess the efficacy and safety of new treatment modalities, alongside studies optimizing existing treatment protocols for various CNS tumors. - Radiological and Imaging Advances:
Research on advanced imaging techniques, including MRI, PET, and radiomics, to enhance tumor diagnosis, monitoring, and treatment response evaluation. - Quality of Life and Patient-Centered Outcomes:
Studies that assess the impact of brain tumors and their treatment on patients' quality of life, neurocognitive function, and psychosocial well-being. - Liquid Biopsy and Biomarkers:
Investigation into the use of liquid biopsies and biomarkers for early detection, monitoring treatment response, and understanding tumor biology. - Neuro-Oncology Care Models:
Research into multidisciplinary approaches and care models that improve the delivery of neuro-oncology services and patient outcomes.
Trending and Emerging
- Precision Medicine and Genomics:
A significant increase in research focusing on precision medicine, including genomic profiling and personalized treatment strategies tailored to the molecular characteristics of tumors. - Immunotherapy and Novel Targets:
Emerging interest in immunotherapy, including checkpoint inhibitors and CAR T-cell therapies, aimed at harnessing the immune system to fight brain tumors. - Artificial Intelligence and Machine Learning:
Growing utilization of AI and machine learning techniques for tumor diagnosis, treatment prediction, and response assessment, indicating a shift towards data-driven approaches in neuro-oncology. - Liquid Biopsy Applications:
Increased research into the applications of liquid biopsies for monitoring treatment response and understanding tumor dynamics, reflecting an innovative approach to patient management. - Quality of Life and Supportive Care Research:
A rising trend in studies focusing on quality of life, neurocognitive outcomes, and psychosocial support for patients with brain tumors, emphasizing holistic care. - Neuro-Oncology in Global Health Contexts:
Emerging themes surrounding the accessibility of neuro-oncology care in low-resource settings, addressing disparities and improving global health outcomes.
Declining or Waning
- Traditional Chemotherapy Studies:
There has been a noticeable decrease in publications focusing solely on traditional chemotherapy regimens for glioblastoma and other CNS tumors, as the field moves toward more targeted and personalized approaches. - Basic Science without Clinical Application:
Research that does not translate into clinical application or relevance has seen a decline, as the journal emphasizes studies that bridge the gap between laboratory findings and clinical practice. - Single-Institution Studies:
The prevalence of single-institution studies has diminished, with a shift towards multicenter collaborations that enhance the generalizability and impact of research findings. - Epidemiological Studies without Molecular Insights:
Epidemiological research that lacks molecular characterization or insights into tumor biology has become less frequent, reflecting a trend towards integrating molecular data into population studies.
Similar Journals
Clinical Medicine Insights-Oncology
Bridging gaps in cancer treatment and management.Clinical Medicine Insights-Oncology is a leading journal published by SAGE Publications Ltd, focusing on the interdisciplinary aspects of oncology. With an open access model since 2007, this journal fosters the dissemination of high-quality research and clinical insights that are crucial for advancing knowledge in cancer treatment and management. Based in New Zealand, it aims to bridge gaps in current oncology practices through the publication of innovative studies, case reports, and reviews. With a respectable ranking in Scopus at #264 out of 404 journals in the oncology category and belonging to the Q3 quartile, it positions itself as a valuable resource for oncologists, researchers, and students committed to enhancing patient outcomes. This journal strives to provide a platform for groundbreaking research that can impact clinical practice and inform policy within the field of oncology.
Brazilian Neurosurgery-Arquivos Brasileiros de Neurocirurgia
Innovating the Future of NeurosurgeryBrazilian Neurosurgery-Arquivos Brasileiros de Neurocirurgia, published by GEORG THIEME VERLAG KG, is a distinguished peer-reviewed open access journal that has been making significant contributions to the field of neurosurgery since its transition to open access in 2015. This Brazilian journal, which is accessible to a global audience, aims to disseminate high-quality research articles, reviews, and case reports that enhance the understanding and practice of neurosurgery and clinical neurology. Despite its current ranking in the Q4 category for both neurology and surgery in 2023, the journal is committed to improving its impact and accessibility for researchers, medical professionals, and students worldwide. As an important platform for innovative ideas and discussions, it takes pride in publishing scientifically rigorous content that informs and shapes the future of neurosurgical practices. With the rise of open access publishing, Brazilian Neurosurgery aligns itself with contemporary trends, making vital research readily available to its diverse readership while nurturing academic collaborations within the neurosurgical community.
Brain and Spine
Innovating the future of neurological research and collaboration.Brain and Spine is a premier academic journal published by ELSEVIER, dedicated to advancing the fields of neuroscience and neurology. With its unique focus on the complex interactions between brain function and spinal health, this journal serves as an essential resource for researchers, clinicians, and students alike. Though currently lacking an official impact factor, its ranking within Scopus highlights its relevance, placing it in the 25th percentile for neuroscience (miscellaneous) and the 23rd percentile within neurology, indicating that while it is a developing journal, it holds potential for significant contributions to the field. Operating under open-access principles, it aims to disseminate valuable findings widely, ensuring that novel insights into neurological health are accessible to a global audience. Brain and Spine seeks to foster interdisciplinary collaboration and innovation, making it an invaluable platform for those striving to enhance our understanding of the brain and spinal cord's intricate functions and interdependencies.
Frontiers in Oncology
Empowering breakthroughs in cancer treatment and care.Frontiers in Oncology is a premier open access journal dedicated to advancing the field of oncology through innovative research and knowledge dissemination. Published by FRONTIERS MEDIA SA since 2011, this journal is based in Switzerland and holds an impressive Q2 ranking in both Cancer Research and Oncology as of 2023, highlighting its significance in the academic community. With its commitment to open access, Frontiers in Oncology ensures that vital research is readily available to researchers, healthcare professionals, and students around the globe, enhancing collaboration and fostering breakthroughs in cancer research. The journal's robust Scopus rankings further illustrate its academic influence, with notable positions in the fields of Oncology and Cancer Research. By covering a wide range of topics within oncology, this journal serves as a vital resource, supporting the rapid evolution of cancer treatment, diagnostics, and patient care strategies.
ACTA NEUROPATHOLOGICA
Leading the Charge in Impactful Neuroscience ResearchACTA NEUROPATHOLOGICA, published by Springer, is a leading journal in the fields of cellular and molecular neuroscience, clinical neurology, and pathology, recognized for its exceptional quality and impactful research. With an impressive impact factor and currently ranked in the Q1 tier across multiple categories in 2023, this journal serves as a premier platform for the dissemination of groundbreaking findings in neuropathology. The journal's robust Scopus rankings highlight its influence, standing at #2 in Pathology and Forensic Medicine and #5 in Clinical Neurology. Since its inception in 1961, ACTA NEUROPATHOLOGICA has provided crucial insights into neurological diseases and disorders, contributing significantly to the advancement of medical science. Aimed at researchers, practitioners, and students alike, this journal fosters a deeper understanding of neurological conditions and encourages innovative approaches within the field. It is essential reading for anyone dedicated to unraveling the complexities of the nervous system.
BRAIN PATHOLOGY
Exploring the Complexities of Neurological DisordersBRAIN PATHOLOGY, published by WILEY, is a leading journal in the fields of neurology, neuroscience, and pathology, recognized for its rigorous peer-review process and high-impact research contributions. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories, BRAIN PATHOLOGY maintains a prominent status, with a Scopus ranking placing it among the top 10% of journals in its fields. Since its inception in 1990, the journal has served as a crucial platform for researchers and clinicians alike, disseminating groundbreaking findings that advance our understanding of brain diseases and injuries. Through its dedication to publishing high-quality, innovative research, BRAIN PATHOLOGY plays a vital role in shaping the future of brain pathology research. While it does not currently offer open access, articles can be accessed through institutional subscriptions. Researchers, professionals, and students are encouraged to contribute to and engage with this esteemed publication to foster knowledge and collaboration within this dynamic field.
ACTA NEUROCHIRURGICA
Pioneering Insights in Clinical Neuroscience and Surgical Excellence.ACTA NEUROCHIRURGICA, published by Springer Wien, stands as a pivotal resource in the realms of neurology and surgery. With its long-standing tradition dating back to 1950, this esteemed journal not only contributes to the advancement of clinical neurology but also excels in surgical methodologies, evidenced by its impressive ranking in the Q1 category for Surgery and Q2 for Neurology (Clinical). With a robust Scopus ranking placing it in the top 20% of surgery journals and the 55th percentile in clinical neurology, it demonstrates a significant impact within its field. Researchers, professionals, and students alike benefit from its rigorously peer-reviewed articles that encompass a wide scope of both theoretical and practical insights. Although not an open-access journal, ACTA NEUROCHIRURGICA remains essential for anyone committed to keeping up with the latest discoveries and innovations in neurosurgery and neuroscience. Located in the heart of Austria at Prinz-Eugen-Strasse 8-10, A-1040 Vienna, this journal continues to be a cornerstone for scholarly communication, guiding future research directions and fostering collaborations among experts.
Advances in Rheumatology
Empowering discoveries in rheumatic disease management.Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.
ONCOLOGY
Leading the charge against cancer with rigorous scholarship.ONCOLOGY is a prestigious journal published by KARGER, dedicated to advancing the field of cancer research and treatment. Established in 1948, this peer-reviewed journal has established a significant presence in the medical community, reflected by its impressive impact factor and Q2 category rankings in both Cancer Research and Oncology as of 2023. With a focus on groundbreaking research and comprehensive reviews, ONCOLOGY serves as a crucial resource for researchers, clinicians, and students interested in the latest developments in the fight against cancer. Although it currently does not offer open access, the journal's reputation ensures that it reaches a wide audience in academia and clinical practice. Its commitment to excellence is underscored by its consistent rankings in key disciplines, making it a vital publication for anyone involved in cancer research, biology, or associated medical fields. The journal is headquartered in Basel, Switzerland, positioning it at the heart of European medical research.
CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE
Your Resource for Cutting-Edge Neurological ResearchCESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE is a prominent scientific journal focusing on the fields of neurology and neurosurgery, published by the esteemed Czech Medical Society. Since its inception in 1973, the journal has aimed to disseminate significant research and advancements in clinical neurology and surgery, contributing to the body of knowledge for professionals and researchers in these fields. Operating under a non-open access model, it maintains a dedicated readership interested in valuable insights from the latest studies and clinical practices. The journal is currently classified in the Q4 category in both Neurology (Clinical) and Surgery, reflecting its ongoing efforts to provide a platform for impactful research, despite being ranked in the lower percentiles within Scopus. Based in Prague, Czech Republic, this journal not only serves as a repository of clinical findings but also encourages collaboration and scholarly dialogue among neurologists and neurosurgeons, driving the field towards further innovations in patient care. With coverage extending from 1973 to 2024, it stands as a key resource for those committed to advancing neurological and surgical sciences.